Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for CASI Pharmaceuticals, Inc. (CASI)

« Back to company index

CASI Chatter Timeline

Stock Ticker for CASI

Most Active Tweeters for CASI

UserTweets
@SwingTradeBot 2
@ConsumerFeed 1
@chaffeybreeze 1
@IRAMarketReport 1
@dispatchtribune 1

Recent Tweets for CASI

OlympiaReport @OlympiaReport
CASI Pharmaceuticals $CASI Share Price Passes Below 50 Day Moving Average of $3.12 https://t.co/QCCO07ugmD
July 12th 2019, 9:07pm
dispatchtribune @dispatchtribune
CASI Pharmaceuticals $CASI Stock Price Passes Below 50 Day Moving Average of $3.12 https://t.co/pSzds6LCPh
July 12th 2019, 9:07pm
SwingTradeBot @SwingTradeBot
Rose Above Upper Bollinger Band today: $MBRX $CASI ... https://t.co/AyIukUGmib
July 11th 2019, 2:07pm
SwingTradeBot @SwingTradeBot
Rose Above 50 DMA today: $CASI ... https://t.co/qwiJH6vr1O
July 10th 2019, 3:07pm
IRAMarketReport @IRAMarketReport
-$0.09 EPS Expected for CASI Pharmaceuticals Inc $CASI This Quarter https://t.co/XrlVok8Vzi #markets
July 2nd 2019, 8:07pm
chaffeybreeze @chaffeybreeze
-$0.09 EPS Expected for CASI Pharmaceuticals Inc $CASI This Quarter https://t.co/A0YPtX1BQV #stocks
July 2nd 2019, 8:07pm
ConsumerFeed @ConsumerFeed
Zacks: Brokerages Expect CASI Pharmaceuticals Inc $CASI Will Announce Earnings of -$0.09 Per Share https://t.co/bOh9hUcfnm
July 2nd 2019, 8:07pm
macondailynews @macondailynews
CASI Pharmaceuticals $CASI Lowered to Sell at BidaskClub https://t.co/Fsdds8TzJv
July 1st 2019, 3:07am
TheMarketsDaily @TheMarketsDaily
CASI Pharmaceuticals $CASI Lowered to Sell at BidaskClub https://t.co/O7v1Ikc6BG
July 1st 2019, 3:07am
OlympiaReport @OlympiaReport
Analysts Anticipate CASI Pharmaceuticals Inc $CASI Will Announce Earnings of -$0.09 Per Share https://t.co/LbZhgLtt0w
June 30th 2019, 1:06pm
WeekHerald @WeekHerald
-$0.09 Earnings Per Share Expected for CASI Pharmaceuticals Inc $CASI This Quarter https://t.co/4dIp0WrXZV
June 30th 2019, 1:06pm
midetimes @midetimes
BidaskClub Lowers CASI Pharmaceuticals $CASI to Sell https://t.co/KqA08pmzFP #stocks
June 30th 2019, 8:06am
dailymailtimes @dailymailtimes
BidaskClub Lowers CASI Pharmaceuticals $CASI to Sell https://t.co/rTP5HWxMCI #investing
June 30th 2019, 8:06am
dailypoliticaln @dailypoliticaln
BidaskClub Lowers CASI Pharmaceuticals $CASI to Sell https://t.co/Txcn0mecjn
June 30th 2019, 8:06am
WatchlistN @WatchlistN
CASI Pharmaceuticals $CASI Stock Rating Lowered by BidaskClub https://t.co/X4oVTLWakL
June 30th 2019, 8:06am
CrossStocks @CrossStocks
PHRX Daily Chart: Turning bullish here Chart https://t.co/koR72KeCBP $PHRX $CASI https://t.co/qkaEPSTmGl
June 29th 2019, 3:06pm
ZolmaxNews @ZolmaxNews
BidaskClub Downgrades CASI Pharmaceuticals $CASI to Sell https://t.co/KnYiFtO9vj
June 29th 2019, 6:06am
ChartMill @ChartMill
The Debt to Equity ratio for $CASI is way better than the industry averages. https://t.co/5eIoYgjPGG https://t.co/UG71V2sb6Z
June 28th 2019, 3:06pm
TickerReport @TickerReport
CASI Pharmaceuticals $CASI Downgraded by BidaskClub to “Sell” https://t.co/zyRoMTC1Ur
June 28th 2019, 9:06am
ConsumerFeed @ConsumerFeed
CASI Pharmaceuticals $CASI versus Surface Oncology $SURF Head-To-Head Analysis https://t.co/iXtpVolFHh
June 27th 2019, 4:06am
AmericanBanking @AmericanBanking
Zacks: Analysts Anticipate CASI Pharmaceuticals Inc $CASI to Post -$0.09 Earnings Per Share https://t.co/rMBWy1Vkoq #stocks
June 25th 2019, 12:06pm
TickerReport @TickerReport
Contrasting Surface Oncology $SURF and CASI Pharmaceuticals $CASI https://t.co/rdpwAV9Qgw
June 25th 2019, 3:06am
WatchlistN @WatchlistN
Zacks: CASI Pharmaceuticals Inc $CASI Receives Consensus Rating of “Strong Buy” from Analysts https://t.co/Gvdrd3u2J0
June 24th 2019, 9:06pm
midetimes @midetimes
Brokerages Anticipate CASI Pharmaceuticals Inc $CASI to Announce -$0.09 Earnings Per Share https://t.co/ipiHWpYHYb #stocks
June 24th 2019, 9:06pm
dailymailtimes @dailymailtimes
Brokerages Anticipate CASI Pharmaceuticals Inc $CASI to Announce -$0.09 Earnings Per Share https://t.co/TC9LIvJ6bv #investing
June 24th 2019, 9:06pm
dailypoliticaln @dailypoliticaln
Brokerages Anticipate CASI Pharmaceuticals Inc $CASI to Announce -$0.09 Earnings Per Share https://t.co/9Jl6B0NmsP
June 24th 2019, 9:06pm
ZacksSmallCap @ZacksSmallCap
$CASI Pharmaceuticals making headway towards commercialization https://t.co/BiLNf7ksA0 https://t.co/I2OMdHK77A
June 24th 2019, 12:06pm
ProVesting @ProVesting
$BMY $CASI: Week In Review: Immunotherapies Dominate The Week’s China …: https://t.co/hWZK30EUuB
June 24th 2019, 7:06am
HeadlinesFin @HeadlinesFin
Is Casi Pharmaceuticals Inc $CASI a Buy? The Stock Reported more Sellers https://t.co/v3w0cRLDMQ
June 23rd 2019, 9:06am
TickerReport @TickerReport
CASI Pharmaceuticals Inc $CASI Given $7.59 Average Price Target by Brokerages https://t.co/Tv6HPgx4y8
June 22nd 2019, 9:06am
InsiderAlertsIA @InsiderAlertsIA
$CASI: New Insider Filing on 10%+ Owner ZHOU QUAN: https://t.co/JAwMKRyS2N
June 21st 2019, 5:06pm
AmericanBanking @AmericanBanking
Analyzing CASI Pharmaceuticals $CASI & Surface Oncology $SURF https://t.co/iflW7P4pRg #stocks
June 20th 2019, 6:06pm
smallcapwatch @smallcapwatch
RT @ahighelevation: $CASI Pharmaceuticals making headway towards commercialization #biotech #smallcap https://t.co/FiO5nlIdRu https://t.co/…
June 20th 2019, 1:06pm
ahighelevation @ahighelevation
$CASI Pharmaceuticals making headway towards commercialization #biotech #smallcap https://t.co/FiO5nlIdRu https://t.co/Fk3TXWefok
June 20th 2019, 1:06pm
TickerReport @TickerReport
Head to Head Review: CASI Pharmaceuticals $CASI and Jounce Therapeutics $JNCE https://t.co/kEwD1lnBYy
June 19th 2019, 8:06pm
1stOncology @1stOncology
#CASIPharmaceuticals Acquires Worldwide Rights To Commercialize #antiCD19TCellTherapy $CASI https://t.co/UYtvoNBeSZ
June 19th 2019, 8:06am
AmericanBanking @AmericanBanking
Head-To-Head Comparison: Oncobiologics $ONS and CASI Pharmaceuticals $CASI https://t.co/Mjhc5aiiAg #stocks
June 19th 2019, 4:06am
fintel_io @fintel_io
$CASI / CASI Pharmaceuticals files form 8-K https://t.co/HsbVnLByxj - Entry into a Material Definitive Agreement, F… https://t.co/Ms4YbIvL7J
June 18th 2019, 4:06pm
AmericanBanking @AmericanBanking
Zacks: CASI Pharmaceuticals Inc $CASI Given $7.59 Average Price Target by Analysts https://t.co/vtgvBgjRaG #stocks
June 18th 2019, 12:06am
MaisaCorp @MaisaCorp
$CASI has signed an agreement for the exclusive worldwide license and commercialization rights to an autologous an… https://t.co/ROT7MfkYbl
June 17th 2019, 5:06pm
StockNewsNow @StockNewsNow
$CASI CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy https://t.co/wCEjWwjhwL
June 17th 2019, 12:06pm
NewsQuantified @NewsQuantified
$CASI Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy, Stock jumps +14.65% #CASIPharmaceuticals https://t.co/H9jyNsM5yv
June 17th 2019, 9:06am
trentkelp @trentkelp
RT @OpenOutcrier: $CASI (+9.9% pre) CASI Pharma (CASI) Reports Acquisition of Worldwide Rights To Commercialize anti-CD19 T-cell Therapy -…
June 17th 2019, 9:06am
Briefingcom @Briefingcom
$CASI: CASI Pharma signs license agreement for exclusive worldwide license and commercialization rights to an... https://t.co/jcZ0iw9uNh
June 17th 2019, 9:06am
OpenOutcrier @OpenOutcrier
$CASI (+9.9% pre) CASI Pharma (CASI) Reports Acquisition of Worldwide Rights To Commercialize anti-CD19 T-cell Ther… https://t.co/Hp70sNgTpy
June 17th 2019, 8:06am
startupxfactor @startupxfactor
RT @MarketCurrents: $CASI - CASI in-licenses rights to anti-CD19 T-cell therapy; shares up 5% premarket https://t.co/4W1zi5eCgw
June 17th 2019, 7:06am
MarketCurrents @MarketCurrents
$CASI - CASI in-licenses rights to anti-CD19 T-cell therapy; shares up 5% premarket https://t.co/4W1zi5eCgw
June 17th 2019, 7:06am
ez_alertz @ez_alertz
$CASI CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy https://t.co/oU3rg4LeVG
June 17th 2019, 7:06am
CHItraders @CHItraders
$CASI Pharma Acquires Worldwide Rights to Commercialize Anti-CD19 T-Cell Therapy From Juventas Cell Therapy, CASI t… https://t.co/mjDfd4NaiV
June 17th 2019, 7:06am
ThisLincolnian @ThisLincolnian
CASI Pharmaceuticals $CASI Stock Rating Upgraded by BidaskClub https://t.co/FFhmiLZYUP
June 17th 2019, 3:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.